The sixth meeting of the GLG, Session 6 'Global Antibiotic Research and Development Partnership (GARDP)' presentation.
Manica Balasegaram, Executive Director, GARDP, discussed the partnership’s work on clinical development of antimicrobials for priority pathogens and populations, as well as the work of the SECURE early access initiative, and recommended that governments should finance late-stage clinical development mainly in highly endemic countries and LMICs.
WHO Team
One Health Global Leaders Group on Antimicrobial Resistance
Information notes
Session 6, Presentation 4, Global Antibiotic Research and Development Partnership (GARDP)
The sixth meeting of the GLG, Session 6 'Global Antibiotic Research and Development Partnership (GARDP)' presentation.
Manica Balasegaram, Executive Director, GARDP, discussed the partnership’s work on clinical development of antimicrobials for priority pathogens and populations, as well as the work of the SECURE early access initiative, and recommended that governments should finance late-stage clinical development mainly in highly endemic countries and LMICs.
WHO Team
One Health Global Leaders Group on Antimicrobial Resistance
Statements and calls to action
Session 6, Presentation 4, Global Antibiotic Research and Development Partnership (GARDP)
The sixth meeting of the GLG, Session 6 'Global Antibiotic Research and Development Partnership (GARDP)' presentation.
Manica Balasegaram, Executive Director, GARDP, discussed the partnership’s work on clinical development of antimicrobials for priority pathogens and populations, as well as the work of the SECURE early access initiative, and recommended that governments should finance late-stage clinical development mainly in highly endemic countries and LMICs.
WHO Team
One Health Global Leaders Group on Antimicrobial Resistance
Meeting reports
Session 6, Presentation 4, Global Antibiotic Research and Development Partnership (GARDP)
The sixth meeting of the GLG, Session 6 'Global Antibiotic Research and Development Partnership (GARDP)' presentation.
Manica Balasegaram, Executive Director, GARDP, discussed the partnership’s work on clinical development of antimicrobials for priority pathogens and populations, as well as the work of the SECURE early access initiative, and recommended that governments should finance late-stage clinical development mainly in highly endemic countries and LMICs.
WHO Team
One Health Global Leaders Group on Antimicrobial Resistance
Presentations and Photos
Presentation from the GLG information Session on the establishment of The Independent Panel on Evidence for Action against Antimicrobial Resistance (IPEA)
Representing the Quadripartite Joint Secretariat (QJS), Dr. Sheila Aggarwal-Khan, provided a detailed briefing on the key elements of institutional design...
Session 1 - Science to inform policy: Implementing UNGA targets on AMRThe session focused on key targets in the 2024 UNGA political declaration on AMR...
Session 1 - Science to inform policy: Implementing UNGA targets on AMRThe session focused on key targets in the 2024 UNGA political declaration on AMR...
Session 1 - Science to inform policy: Implementing UNGA targets on AMRThe session focused on key targets in the 2024 UNGA political declaration on AMR...
Session 1 - Science to inform policy: Implementing UNGA targets on AMRThe session focused on key targets in the 2024 UNGA political declaration on AMR...
The sixth meeting of the GLG, Session 1 Implementing the GLG action plan and priorities presentation.Haileyesus Getahun, Director of the Quadripartite...
Session 1 - Science to inform policy: Implementing UNGA targets on AMRThe session focused on key targets in the 2024 UNGA political declaration on AMR...
Session 1 - Science to inform policy: Implementing UNGA targets on AMRThe session focused on key targets in the 2024 UNGA political declaration on AMR...
Photos from the GLG ESCMID AMR Science Policy Forum - 11 April 2025
For the third successive year, the Global Leaders Group (GLG) on Antimicrobial Resistance (AMR) and the European Society for Microbiology and Infectious Diseases (ESCMID) co-hosted an AMR Science-Policy Forum on the sidelines of ESCMID Global.
The theme of the 2025 Forum was selected to focus presentations and discussion on how science and evidence can guide policy actions to support translation of commitments and targets in the 2024 United Nations General Assembly (UNGA) Political Declaration on AMR into action and results.
The 2024 United Nations General Assembly Political Declaration on Antimicrobial Resistance (AMR) invited the Quadripartite organizations (FAO, UNEP, WHO,...
Representing the Quadripartite Joint Secretariat (QJS), Dr. Sheila Aggarwal-Khan, provided a detailed briefing on the key elements of institutional design...
Photos from the GLG-ESCMID AMR Event at ESCMID Global 2024
This high-level event is intended to position research, science and implementation into the political
agenda of AMR and address the pressing needs of AMR across all sectors. It is a critical time for this
discussion and alignment leading up to the United Nations General Assembly High-level Meeting on
AMR to be held in September 2024 in New York, USA. Access photos from the event here.
Presentations from the GLG information session on the antibacterial pipeline and access crisis - 17 May 2023
Malin Grape, Ambassador on Antimicrobial Resistance, Ministry of Health and Social Affairs in Sweden presented 'The antibiotic Research & Development...
Dr Alexandra Cameron, Senior Expert and Unit Head a.i., Impact Initiatives and Research Coordination, Global Cooperation and Partnerships Department, AMR...
Kevin Outterson, Executive Director of CARB X and Austin B. Fletcher Professor at Boston University presented 'The innovation problem: shortfall of public...
The 2024 United Nations General Assembly Political Declaration on Antimicrobial Resistance (AMR) invited the Quadripartite organizations (FAO, UNEP, WHO,...
Representing the Quadripartite Joint Secretariat (QJS), Dr. Sheila Aggarwal-Khan, provided a detailed briefing on the key elements of institutional design...
The sixth meeting of the GLG, Session 6 'Global Antibiotic Research and Development Partnership (GARDP)' presentation.
Manica Balasegaram, Executive Director, GARDP, discussed the partnership’s work on clinical development of antimicrobials for priority pathogens and populations, as well as the work of the SECURE early access initiative, and recommended that governments should finance late-stage clinical development mainly in highly endemic countries and LMICs.
WHO Team
One Health Global Leaders Group on Antimicrobial Resistance
Photos from the sixth meeting of the GLG
The sixth official meeting of the Global Leaders Group on AMR was held in person for the first time in St Lawrence Gap, Barbados on 7 and 8 February 2023. Meeting photos are available here.
Photos from the GLG AMR Reception at WHA 76
In advance of the United Nations General Assembly High-level Meeting on AMR in 2024, the GLG hosted a reception for Ministers of Health and other officials during the 76th World Health Assembly in Geneva, Switzerland on May 22, 2023 to galvanize political action for the global AMR response. Access photos here.
Photos from the ninth meeting of the GLG
The ninth official meeting of the Global Leaders Group on AMR was held in Sigtuna, Sweden on 6 and 7 May 2024. Meeting photos are available here.
